1. Home
  2. FLNT vs NSPR Comparison

FLNT vs NSPR Comparison

Compare FLNT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$2.96

Market Cap

93.4M

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.59

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNT
NSPR
Founded
2001
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.4M
81.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FLNT
NSPR
Price
$2.96
$1.59
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
$2.50
$4.00
AVG Volume (30 Days)
78.9K
41.8K
Earning Date
02-27-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$212,352,000.00
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
$11.71
$75.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.04
52 Week Low
$1.50
$1.51
52 Week High
$3.56
$3.80

Technical Indicators

Market Signals
Indicator
FLNT
NSPR
Relative Strength Index (RSI) 60.74 34.22
Support Level $2.81 $1.51
Resistance Level $3.56 $1.66
Average True Range (ATR) 0.27 0.14
MACD 0.02 -0.03
Stochastic Oscillator 60.29 10.94

Price Performance

Historical Comparison
FLNT
NSPR

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: